Regan Daniel Paul
Chief Commercial Officer at INTERCEPT PHARMACEUTICALS INC
- Sold, on record
- $13.3M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jan 30, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- INTERCEPT PHARMACEUTICALS INCChief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusualMar 5, 2014 2014
Sold 20,000 shares at $434.69 ($8.7M)
Regan Daniel Paul, Chief Commercial Officer
Sold 100% of holdings ($8.7M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedJul 3, 2014 +120 days
Sold 1 shares at $250.00 ($250)
Regan Daniel Paul, Chief Commercial Officer
Sold 0.1% of holdings ($353k position)1,410 shares leftFiling
- 3 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusualAug 12, 2014 +40 days
Sold 8,124 shares at $325.70 ($2.6M)
Regan Daniel Paul, Chief Commercial Officer
Sold 85.2% of holdings ($3.1M position)1,410 shares leftFiling
- 4 Form 4 sale INTERCEPT PHARMACEUTICALS INCPlan not statedJan 5, 2015 +146 days
Sold 146 shares at $176.49 ($26k)
Regan Daniel Paul, Chief Commercial Officer
Sold 10.4% of holdings ($249k position)1,264 shares left0x usual sizeFiling
- 5 Form 4 sale INTERCEPT PHARMACEUTICALS INCUnusualJan 30, 2015 +25 days
Sold 9,847 shares at $201.07 ($2M)
Regan Daniel Paul, Chief Commercial Officer
Sold 88.6% of holdings ($2.2M position)1,264 shares left2.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2015 | Feb 3, 2015 | INTERCEPT PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 9,847 | $2M | 88.6% | Unusual | SEC |
| Jan 5, 2015 | Jan 7, 2015 | INTERCEPT PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 146 | $26k | 10.4% | Plan not stated | SEC |
| Aug 12, 2014 | Aug 15, 2014 | INTERCEPT PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 8,124 | $2.6M | 85.2% | Unusual | SEC |
| Jul 3, 2014 | Jul 8, 2014 | INTERCEPT PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 1 | $250 | 0.1% | Plan not stated | SEC |
| Mar 5, 2014 | Mar 7, 2014 | INTERCEPT PHARMACEUTICALS INC | Chief Commercial Officer | Form 4 sale | 20,000 | $8.7M | 100.0% | Unusual | SEC |